Background: Diffuse large B-cell lymphoma (DLBCL) has been the most common kind of non-Hodgkin lymphoma (NHL), representing for roughly 24% of new instances per year. The HMG box 1 protein is a nuclear DNAbinding protein that was identified more than thirty years ago. It binds to DNA and functions as a cofactor in the transcription of genes. Overexpression of HMGB1 was being discovered in many cancers, including breast cancer, gastric cancer, and non-Hodgkin lymphoma. Aim of the study: to see how high mobility group box 1 protein levels are affected by DLBCL and how chemotherapy affects HMGB1 levels in DLBCL patients. Patients and Methods: This study was conducted out in oncology department of Al-Hussein University hospital. Two groups of patients were formed. Group (A): composed of 35 patients with DLBCL for whom pre-treatment and post-treatment level of HMGB1 protein were measured. Group (B): composed of 35 normal subjects act as a control group. All procedures followed Al-Azhar University Ethical Committee regulations. Results: there is statistically significant improvement after chemotherapy as t value equaled (8.632) with P-value (0.000). Also, when comparing pre-value with normal, paired t test equaled (10.16) with P-value (0.000). Using ROC curve, it was stated that area under the curve equaled 1 with standard error 0 and P=0.017. Conclusion:The HMG box 1 protein is a significant indicator in patients with DLBCL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.